Background
Primary spinal infections (PSI) account for 2–5% of all infectious bone diseases [1‐3] and mainly include spondylodiscitis (SD) and isolated spinal epidural empyema (ISEE) [4‐7]. The incidence of PSI was previously reported to be 0.2–3 cases per 100.000 persons per year [8‐10], however current age-standardized incidence rate in Germany was estimated to be 30 per 250.000 persons per year based on data from the Federal Statistical Office (2015) [11].
Despite diagnostic and therapeutic improvements, PSI remains a challenging disease with a high mortality rate [12]. Microbiological analysis of the causative bacteria plays a key role in the diagnostic and treatment of PSI [13], thus effective antibiotic treatment depends on the correct identification of the underlying bacterial species and their antimicrobial susceptibility.
Anzeige
To verify an infection, at least two peripheral blood cultures and several biopsies should be submitted for microbiological diagnostics [14]. Bacterial detection rate in PSI is successful in 50–83% of cases [15, 16]. In previous studies, methicillin-susceptible Staphylococcus aureus (MSSA) was the most detected bacterium in PSI, followed by coagulase-negative Staphylococci (CoNS) [12, 17‐21].
A better understanding of the clinico-microbiological differences between the various bacterial species would improve the treatment and outcome, thus affecting the complication rate and length of stay in the hospital and intensive care unit (ICU). We analyzed the bacterial spectrum in our cohort of 187 surgical patients and assessed its impact on clinical disease course to determine a reproducible phenotyping of a bacterial population in SD and ISEE.
Methods
Study design and patient data
We performed a retrospective analysis of consecutive spontaneous PSI cases from 2002 to 2022 treated surgically at our Neurosurgery University Spine Center in Dresden, Germany. All patients with proven PSI who underwent surgical treatment were included. We excluded five cases with non-pyogenic pathogens, sixteen cases without any evidence of pathogens, eight patients with only conservative treatment, and twelve patients with intradural infection. A total of 187 patients were included in the analysis (Fig. 1).
Fig. 1
Study design: One hundred eighty-seven patients with proven pyogenic spondylodiscitis (SD: 125) and isolated spinal epidural empyema (ISEE: 62) were included in this study. Forty-one patients were excluded based on exclusion criteria
×
![]()
Anzeige
The study was approved by the local ethics committee of the Carl Gustav Carus University Hospital in Dresden (Ref: BO-EK-17,012,022). Patients’ data were collected via the ORBIS system (ORBIS, Dedalus, Bonn, Germany) and neuroimaging studies through the IMPAX system (IMPAX, Impax Asset Management Group plc, London, UK).
Electronic medical records were first pseudonymized and then analyzed for various laboratory, microbiologic, histopathologic, clinical, and radiologic parameters. Relapse was defined as clinical, microbiological, and/or radiological progression during or after treatment up to the final follow-up of one year. We evaluated relapse rate, disease-related mortality, complication rate (sepsis [Soong, 2012 #49], septic embolism [Stawicki, 2013 #50], infective endocarditis [Barnett, 2016 #51]), and therapeutic modalities. Moreover, the detection rate of bacteria in blood culture, intraoperative specimen, and computed tomography (CT)-guided biopsy of psoas abscess was evaluated. To determine the source of infection in SD or ISEE, it is first necessary to understand the pathogenesis of spinal infections, which can begin in three different ways: direct contamination after surgery, adjacent spread from a neighboring soft tissue infection, or hematogenous spread from a distant source of infection such as pneumonia. If the spinal infection clearly emerged from one of these three routes and had the same pathogen, we called it the source of infection.
Clinico-microbiological management
Diagnosis and treatment
SD and ISEE were diagnosed on the basis of clinical, laboratory, microbiological, and radiological findings (magnetic resonance imaging (MRI) and CT) according to the guidelines of the Infectious Diseases Society of America (IDSA) [14]. Clinical and laboratory parameters included back or neck pain, fever, leukocyte count, C-reactive protein (CrP), and Procalcitonin.
Depending on the clinical condition, at least two blood cultures were taken for microbiological diagnosis before antibiotic therapy was initiated, while some patients were initially treated with antibiotics in a peripheral hospital due to their severe clinical condition. In addition, tissue samples taken during open surgery and samples obtained by CT-guided biopsies were also used for microbiological analysis. We treated all patients surgically in different procedures depending on the location of the infection, clinical and laboratory findings, and severity of the bone defects.
Patients with hemodynamic instability, sepsis, septic shock, or progressive neurological symptoms underwent empiric antibiotic therapy (EAT) immediately after collection of blood cultures. On the other hand, patients with stable hemodynamic and neurological symptoms received targeted antibiotic therapy (TAT) after pathogen detection in the blood culture, image-guided biopsy, or open surgery. In the case of culture-negative spondylodiscitis (blood culture, image-guided biopsy, and surgery), we initiated an EAT. EAT was based on the suspected pathogen, suspected source of infection, clinical condition, epidemiologic risk, and local historical in vitro susceptibility data. In most cases, our therapy was a combination of vancomycin with ceftriaxone or vancomycin with piperacillin/tazobactam.
The first-line therapy in our clinic for MSSA was flucloxacillin (1. 5 − 2 g intravenously (IV) every (e) 4–6 h), β-haemolytic Streptococci or penicillin-susceptible Enterococci penicillin G (20–24 million units IV e 24 h), Enterobacteriaceae or Pseudomonas aeruginosa cefepime (2 g IV e 8–12 h), MRSA, CoNS, or penicillin-resistant Enterococci vancomycin (IV 15–20 mg/kg e 12 h with loading dose and monitoring of serum levels).
In patients with foreign body infections or osteosynthesis material (fixator as therapy), a combination such as flucloxacillin or vancomycin with rifampicin was used. Depending on the clinical condition, infection parameters and MRI findings, the IV-therapy was switched to an oral therapy for another 4 weeks.
Microbiological assessment
Blood culture
Both the aerobic and anaerobic blood culture flasks (BACTEC Plus Aerobic/F and Anerobic/F) were incubated for a maximum of 14 days in the BACTECTM FX blood culture machine (BD, Heidelberg, Germany). After cultural growth was indicated, a Gram staining was performed. Furthermore, an agar diffusion test was carried out using a Müller-Hinton agar (bioMérieux, Nürtingen, Germany) and test platelets (bestbion dx, Köln, Germany) for specific antibiotics to provide a provisional resistogram. Cultivation from aerobic culture was performed by plating sample on a Columbia blood agar (bioMérieux, Nürtingen, Germany), on chocolate agar (bioMérieux, Nürtingen, Germany), bile Chryosidine Glycerol Agar (Becton Dickinson, Heidelberg, Germany), Sabauroud glucose agar (Becton Dickinson, Heidelberg, Germany) and on Columbia CNA agar with 5% sheep blood (Becton Dickinson, Heidelberg, Germany). HCG agar (Sifin Diagnostics GmbH, Berlin, Germany) was used to detect anaerobic bacterial. It was incubated in a culture pot “AnaeroJar” (Becton Dickinson, Heidelberg, Germany) under absorption of oxygen using AnaeroGen (Oxoid, Wesel, Germany). The aerobic cultures were incubated at 37 degrees for 24 h. The HCG agar was incubated for 48 h. As soon as bacterial colonies were detectable, the species were identified using MALDI TOF MS (Bruker Daltonics GmbH, Bremen, Germany).
Tissue from CT-guided or intraoperative sampling
Tissue obtained intraoperatively or CT-guided was placed directly in the operating theatre in Schaedler boullions (bioMérieux, Nürtingen, Germany) and these were subsequently sent to the Institute of Medical Microbiology and Virology, Carl Gustav Carus University Hospital in Dresden for analysis. There, the boullions were first incubated at 37 degrees and examined for turbidity after 48 h. Once turbidity was detected, the culture suspension was plated on Columbia Blood Agar (bioMérieux, Nürtingen, Germany) and HCB Agar (bioMérieux, Nürtingen, Germany). Aerobic culture growth was checked for the first time after 24 h and anaerobic culture growth after another 48 h.
Antimicrobial susceptibility
The final antimicrobial susceptibility testing for aerobic bacterial species was performed using the VITEK 2 system (bioMérieux, Nürtingen, Germany) and the respective antimicrobial susceptibility test (AST) cards (bioMérieux, Nürtingen, Germany). The analysis was performed according to the guidelines of the manufacturer. Antimicrobial susceptibility profiles of anaerobic bacteria were generated using the ATB ANA System (bioMérieux, Nürtingen, Germany) or Gradient diffusion tests (bestbion, Cologne, Germany).
Bacterial species that are known to be of definite human pathogenic relevance have been included in the evaluation if they occur in already one sample. In contrast, low-pathogenic species (e.g., facultative pathogens) were only included in the evaluation if they were detected in at least two independent clinical samples. The results of the resistograms were then compared to assess whether two isolates were of the same origin or not.
Formation of groups
The detected bacteria were grouped in gram-positive bacteria (GPB) and gram-negative bacteria (GNB) and further subgrouped according to the taxonomic classification, specific resistance phenotypes or characteristic properties (MSSA, Streptococcus spp. and Enterococcus spp. (SE), CoNS, methicillin-resistant Staphylococcus aureus (MRSA), bacillus spp., Pseudomonas aeruginosa, Enterobacterales (E), and anaerobic bacteria). Furthermore, Enterococcus spp. and infections showing a polymicrobial spectrum were analyzed separately.
Statistical analysis
Data were statistically analysed with the SPSS software package (SPSS Statistics 28, IBM, Armonk, New York, USA). Descriptive statistics were used, and categorical variables were adjusted by Fisher exact tests or chi-square tests. Numerical variables were analysed with Mann-Whitney U tests. All statistical tests were two-sided, and a p value p < 0.05 was considered statistically significant.
Results
Demographics and baseline characteristics
We included 187 patients (males: 120, 64.2% vs. females: 67, 35.8%, p < 0.001) aged 68 [23–90] y, median [interquartile range] with SD (125, 66.8%) and ISEE (62, 33.2%), of whom 162 (86.6%) had GPB and 25 (13.4%) had GNB (Table 1).
Table 1
Baseline characteristics
Baseline characteristics | N = 187 | Percentage |
|---|---|---|
Male | 120 | 64.2% |
Female | 67 | 35.8% |
Age | 68 [23–90] y* | – |
Spondylodiscitis | 125 | 66.8% |
Isolated spinal epidural empyema | 62 | 33.2% |
Gram-positive bacteria | 162/187 | 86.6% |
Gram-negative bacteria | 25/187 | 13.4% |
Surgery | 187 | 100% |
Blood cultures | 187 | 100% |
Psoas abscess | 116 | 62.0% |
CT-guided biopsy of Psoas | 65/116 | 56.0% |
Empiric antibiotic therapy (EAT) | 122 | 65.2% |
Targeted antibiotic therapy (TAT) | 65 | 34.8% |
Duration of intravenous antibiotics | 4 [3–6] w* | – |
Duration of total antibiotics | 8 [6–12] w* | – |
Sepsis | 94/187 | 50.3% |
Septic embolism | 50/150 | 33.3% |
Infective endocarditis with vegetation in TTE/TEE | 23/161 | 14.3% |
Relapse rate (clinical, microbiological, and/or radiological progression) | 28/123 | 22.8% |
Disease-related mortality | 10/187 | 5.3% |
Multiple blood cultures and intraoperative samples were taken from all patients, whereas 65 tappable patients (56.0%) out of 116 patients with psoas abscess (62%) underwent CT-guided biopsy. EAT was initially performed in 122 patients (65.2%) and later changed to TAT as soon as the underlying bacterial species was known, while 65 patients (34.8%) were treated directly with a TAT. Patients without antibiotic therapy or with an antibiotic-free period of more than 2 days formed the TAT group, whereas patients with ongoing antibiotic therapy or an antibiotic-free period of less than 2 days formed the EAT group. Patients received intravenous antibiotics for approximately 4 weeks (4 [3‐6] w) and a total of 8 weeks antibiotics (8 [6‐12] w). Sepsis was observed in 94 patients (50.3%), septic embolism in 50 patients (33.3%), and infective endocarditis with vegetation in echocardiography in 23 patients (14.3%). Twenty-eight patients (22.8%) relapsed, and ten patients (5.3%) died from the diseases and their complications (Table 1). To exclude septic embolism, 150 patients (80.2%) underwent radiological examination, 161 patients (86.1%) underwent TTE and TEE, and 123 patients (65.8%) underwent one-year clinical, laboratory, and radiological follow-up to exclude a relapse.
Identified bacteria
MSSA were the most commonly identified bacteria (100, 53.5%), followed by S. epidermidis (18, 9.6%) and Escherichia coli (8, 4.3%). MRSA, Streptococcus anginosus, Streptococcus dysgalactiae, Streptococcus gallolyticus, Streptococcus pneumoniae, and Proteus mirabilis were each identified in 5 cases (2.7%). P. aeruginosa, Cutibacterium acnes, Enterococcus faecalis, and Streptococcus mitis/gordonii were each observed in 4 cases (2.1%). Klebsiella pneumoniae and Streptococcus agalactiae were each isolated in 3 cases (1.6%). Salmonella spp. were found in 2 cases (1.1%). Prevotella bivia, Morganella morganii, Klebsiella oxytoca, Parvimonas micra, Bacillus pumilus, Staphylococcus capitis, and Staphylococcus hominis were each detected in 1 case (0.5%) (Fig. 2).
Fig. 2
Identified bacteria in spondylodiscitis and isolated spinal epidural empyema: This figure shows the detected bacteria in patients with spondylodiscitis (SD) and isolated spinal epidural empyema (ISEE). MSSA: Methicillin-susceptible Staphylococcus aureus, MRSA: Methicillin-resistant Staphylococcus aureus
×
![]()
Anzeige
Gram spectrum of bacteria
Bacterial spectrum was mainly dominated by GPB (GPB: 162, 86.6% vs. GNB: 25, 13.4%, p < 0.001). GPB were observed in 105 SD patients (64.8%) and in 57 ISEE patients (35.2%), while GNB were noted in 20 SD patients (80.0%) and 5 ISEE patients (20%) (p = 0.172). Endocarditis with vegetation in echocardiography occurred solely in GPB (GPB: 23, 16.5% vs. GNB: 0, 0.0%, p = 0.046). GNB showed a different distribution of primary infectious sources compared to GPB, especially more urinary tract infections (GPB: 4, 3.7% vs. GNB: 9, 40.9%, p < 0.001) (Table 2).
Table 2
Gram-positive and Gram-negative bacteria in spinal infections
Entities, complications, and primary source of infection (n = 187) | Gram-positive bacteria (n = 162, 86.6%) | Gram-negative bacteria (n = 25, 13.4%) | p-value* |
|---|---|---|---|
SD | 105/162 (64.8%) | 20/25 (80.0%) | 0.172 |
ISEE | 57/162 (35.2%) | 5/25 (20.0%) | |
Sepsis | 81/162 (50.0%) | 13/25 (52.0%) | 1.0 |
Septic embolism | 46/128 (35.9%) | 4/22 (18.2%) | 0.142 |
Endocarditis | 23/139 (16.5%) | 0/22 (0.0%) | 0.046 |
Relapse rate | 22/103 (21.4%) | 6/20 (30.0%) | 0.394 |
Disease-related mortality | 9 (5.6%) | 1 (4.0%) | 1.0 |
Source of infection (129/187, 69.0%) | |||
Hematogenous spread | < 0.001(1) | ||
Gastrointestinal tract infection | 6/107 (5.6%) | 3/22 (13.6) | |
Respiratory tract infection (pneumonia) | 15/107 (14.0%) | 1/22 (4.5%) | |
Urinary tract infection (urosepsis) | 4/107 (3.7%) | 9/22 (40.9%) | |
Skin infection | 34/107 (31.8%) | 3/22 (13.6%) | |
Foreign body-associated infection (joint replacements, venous access port, prosthetic heart valve, and screws elsewhere in spine) | 20/108 (18.7%) | 3/22 (13.6%) | |
Odontogenic infection | 5/107 (4.7%) | 0/22 (0.0%) | |
Retropharyngeal & prevertebral infection | 4/107 (3.7) | 2/22 (9.1%) | |
Post-interventional | |||
Epidural administration such as spinal infiltration (facet joint, epidural, periradicular) or epidural catheter analgesia | 19/107 (17.8%) | 1/22 (4.5%) | |
Subgroups
Based on detailed review of the detected bacteria, we subgrouped the bacterial species according to the taxonomic classification, specific resistance phenotypes or characteristic properties. GPB excluding anaerobic bacteria (n = 157, 84.0%) were divided into MSSA (n = 100, 53.5%), SE (n = 31, 16.6%), CoNS (n = 20, 10.7%), MRSA (n = 5, 2.7%) and Bacillus spp. (n = 1, 0.5%), while GNB without anaerobic bacteria (n = 24, 12.8%) were grouped into E (n = 20, 10.7%) and P. aeruginosa (n = 4, 2.1%). Anaerobic bacteria (n = 6, 3.2%) included gram-positive C. acnes (n = 4, 2.1%) and P. micra (n = 1, 0.5%) and gram-negative Prevotella bivia (n = 1, 0.5%).
We analyzed and compared all subgroups with more than 20 cases, while small subgroups were evaluated separately (Fig. 3).
Anzeige
Fig. 3
Bacterial subgroups in spondylodiscitis and isolated spinal epidural empyema: This figure demonstrates the subgroups of detected bacteria detected in our cohort. GPB: Gram-positive bacteria, GNB: Gram-negative bacteria. MSSA: Methicillin-susceptible Staphylococcus aureus, MRSA: Methicillin-resistant Staphylococcus aureus, St.: Staphylococcus, S.: Streptococcus, E.: Escherichia, K.: Klebsiella, M.: Morganella, C.: Cutibacterium
×
![]()
Methicillin-susceptible Staphylococcus aureus (MSSA)
MSSA were found less in SD and more in ISEE (SD: 57, 57.0% vs. ISEE: 43, 43.0%) compared to other bacteria (OB) (SD: 68, 78.2% vs. ISEE: 19, 21.8%, p = 0.003).
MSSA was found more in the cervical spine (CS) compared to other bacteria (OB) (MSSA: 41, 41.0% vs. OB:18, 20.7%, p = 0.004), but no differences were observed in samples from the thoracic spine (TS) (MSSA: 45, 45.0% vs. OB: 30, 34.5%, p = 0.178), and samples derived from the lumbar spine (LS) (MSSA: 64, 64.0% vs. OB: 59, 67.8%, p = 0.644).
The sources of infection in MSSA differed in distribution from OB (p < 0.001), particularly in relation to skin infections (MSSA: 26, 41.3% vs. OB: 11, 16.7%) and foreign body-associated infections (MSSA: 5, 7.9% vs. OB: 18, 27.3%) (Table 3).
Table 3
Clinical characteristics of methicillin-susceptible Staphylococcus aureus
Total n = 187 | MSSA (100, 53.5%) | Other bacteria (87, 46.5%) | p-value |
|---|---|---|---|
Sex | M: 63 (63.0%) F: 37 (37.0%) | M:57 (65.5%) F: 30 (34.5%) | 0.761(2) |
Age | 67 [23–90] y | 72 [47–89] y | 0.052(3) |
Spondylodiscitis | 57 (57.0%) | 68 (78.2%) | 0.003(2) |
Isolated spinal epidural empyema | 43 (43.0%) | 19 (21.8%) | |
Sepsis | 56/100 (56.0%) | 38/87 (43.7%) | 0.108(2) |
Septic embolism | 29/79 (36.7%) | 21/71 (29.6%) | 0.389(2) |
Endocarditis | 13/86 (15.1%) | 10/75 (13.3%) | 0.824(2) |
Relapse rate | 10/64 (15.6%) | 18/59 (30.5%) | 0.056(2) |
Disease-related mortality | 6/100 (6.0%) | 4/87 (4.6%) | 0.753(2) |
Length of hospital stay | 31 [9-163] d | 35 [10–165] | 0.182(3) |
Length of intensive care unit stay | 8 [1–53] d | 4 [1–46] d | 0.093(3) |
Spinal localization | |||
Cervical spine | 41 (41.0%) | 18 (20.7%) | 0.004(2) |
Thoracic spine | 45 (45.0%) | 30 (34.5%) | 0.178(2) |
Lumbar spine | 64 (64.0%) | 59 (67.8%) | 0.644(2) |
Bacterial detection via | |||
Blood cultures | 67 (67.0%) | 51 (58.6%) | 0.288(2) |
Intraoperative specimens | 87 (87.0%) | 70 (80.5%) | 0.238(2) |
CT-guided biopsies (37/65) | 23/41 (56.1%) | 14/24 (58.3%) | 1.0(2) |
Source of infection (129/187, 69.0%) | |||
Hematogenous spread | < 0.001(1) | ||
Gastrointestinal tract infection | 2/63 (3.2%) | 7/66 (10.6%) | |
Respiratory tract infection (pneumonia) | 9/63 (14.3%) | 7/66 (10.6%) | |
Urinary tract infection (urosepsis) | 3/63 (4.8%) | 10/66 (15.2%) | |
Skin infection | 26/63 (41.3%) | 11/66 (16.7%) | |
Foreign body-associated infection (joint replacements, venous access port, prosthetic heart valve, and screws elsewhere in spine) | 5/63 (7.9%) | 18/66 (27.3%) | |
Odontogenic infection | 4/63 (6.3%) | 1/66 (1.5%) | |
Retropharyngeal & prevertebral infection | 2/63 (3.2%) | 4/66 (6.1%) | |
Post-interventional | |||
Epidural administration such as spinal infiltration (facet joint, epidural, periradicular) or epidural catheter analgesia | 12/63 (19.0%) | 8/66 (12.1%) | |
Streptococcus spp. and Enterococcus spp. (SE)
Streptococcus spp. and Enterococcus spp. were found more often in SD but less frequently in ISEE (SD: 26, 83.9% vs. ISEE: 5, 6.1%) compared to OB (SD: 99, 63.5% vs. ISEE: 57, 36.5%, p = 0.036).
Endocarditis was found more frequently in the “SE subgroup” than in the “OB subgroup” (SE: 8, 27.6% vs. OB: 15, 11.4%, p = 0.037).
The diagnostic sensitivity for the “SE subgroup” was in intraoperative specimens lower compared to OB (SE: 19, 61.3% vs. OB: 138, 88.5%, p < 0.001), however no differences were observed in blood cultures (SE: 23, 74.2% vs. OB: 95, 60.9%, p = 0.221), and CT-guided biopsies (SE: 7/11, 63.6% vs. OB: 30/54, 55.6%, p = 0.745) (Table 4).
Table 4
Clinical characteristics of Streptococcus spp. und Enterococcus spp
Total n = 187 | Streptococci & Enterococci (31, 16.6%) | Other bacteria (156, 83.4%) | p-value |
|---|---|---|---|
Sex | M: 21 (67.7%) F: 10 (32.3%) | M: 99 (63.5%) F: 57 (36.5%) | 0.688(2) |
Age | 72 [48–89] y | 67 [23–90] y | 0.190(3) |
Spondylodiscitis | 26 (83.9%) | 99 (63.5%) | 0.036(2) |
Isolated spinal epidural empyema | 5 (16.1%) | 57 (36.5%) | |
Sepsis | 16/31 (51.6%) | 78/156 (50.0%) | 1.0(2) |
Septic embolism | 12/27 (44.4%) | 38/123 (30.9%) | 0.184(2) |
Endocarditis | 8/29 (27.6%) | 15/132 (11.4%) | 0.037(2) |
Relapse rate | 6/17 (35.3%) | 22/106 (20.8%) | 0.215(2) |
Disease-related mortality | 3/31 (9.7%) | 7/156 (4.5%) | 0.218(2) |
Length of hospital stay | 38 [10–165] d | 32 [9-163] d | 0.289(3) |
Length of intensive care unit stay | 7 [1–46] d | 6 [1–53] d | 0.944(3) |
Spinal localization | |||
Cervical spine | 23 (74.2%) | 95 (60.9%) | 0.221(2) |
Thoracic spine | 13 (42.0%) | 62 (39.7%) | 0.843(2) |
Lumbar spine | 25 (80.6%) | 98 (62.8%) | 0.064(2) |
Bacterial detection via | |||
Blood cultures | 23 (74.2%) | 95 (60.9%) | 0.221(2) |
Intraoperative specimens | 19 (61.3%) | 138 (88.5%) | < 0.001(2) |
CT-guided biopsies (37/65) | 7/11 (63.6%) | 30/54 (55.6%) | 0.745(2) |
Source of infection (129/187, 69.0%) | |||
Hematogenous spread | 0.344(1) | ||
Gastrointestinal tract infection | 3/24 (12.5%) | 6/105 (5.7%) | |
Respiratory tract infection (pneumonia) | 4/24 (16.7%) | 12/105 (11.4%) | |
Urinary tract infection (urosepsis) | 0/24 (0.0%) | 13/105 (12.4%) | |
Skin infection | 5/24 (20.8%) | 32/105 (30.5%) | |
Foreign body-associated infection (joint replacements, venous access port, prosthetic heart valve, and screws elsewhere in spine) | 6/24 (25.0%) | 17/105 (16.2%) | |
Odontogenic infection | 0/24 (0.0%) | 5/105 (4.8%) | |
Retropharyngeal & prevertebral infection | 1/24 (4.2%) | 5/105 (4.8%) | |
Post-interventional | |||
Epidural administration such as spinal infiltration (facet joint, epidural, periradicular) or epidural catheter analgesia | 5/24 (20.8%) | 15/105 (14.3%) | |
Enterobacterales (E)
The sources of infection in Enterobacterales differed in distribution from OB (p < 0.001), particularly in relation to urinary tract infections (E: 9, 50.0% vs. OB: 4, 3.6%) (Table 5).
Table 5
Clinical characteristics of Enterobacterales
Total n = 187 | Enterobacterales (20, 10.7%) | Other bacteria (167, 89.3%) | p-value |
|---|---|---|---|
Sex | M: 12 (60.0%) F: 8 (40.0%) | M: 108 (64.7%) F: 59 (35.3%) | 0.806(2) |
Age | 72 [54–83] y | 68 [23–90] y | 0.543(3) |
Spondylodiscitis | 16 (80.0%) | 109 (65.3%) | 0.218(2) |
Isolated spinal epidural empyema | 4 (20.0%) | 58 (34.7%) | |
Sepsis | 10/20 (50.0%) | 84/167 (50.3%) | 1.0(2) |
Septic embolism | 3/19 (15.8%) | 47/131 (35.9%) | 0.117(2) |
Endocarditis | 0/18 (0.0%) | 23/143 (16.1%) | 0.078(2) |
Relapse rate | 6/17 (35.3%) | 22/106 (20.8%) | 0.215(2) |
Disease-related mortality | 1/20 (5.0%) | 9/167 (5.4%) | 1.0(2) |
Length of hospital stay | 33 [15–70] d | 32 [9-165] d | 0.629(3) |
Length of intensive care unit stay | 4 [1–17] d | 7 [1–53] d | 0.093(3) |
Spinal localization | |||
Cervical spine | 5 (25.0%) | 54 (32.3%) | 0.616(2) |
Thoracic spine | 5 (25.0%) | 70 (41.9%) | 0.227(2) |
Lumbar spine | 14 (70.0%) | 109 (65.3%) | 0.805(2) |
Bacterial detection via | |||
Blood cultures | 12 (60.0%) | 106 (63.5%) | 0.809(2) |
Intraoperative specimens | 16 (80.0%) | 141 (84.4%) | 0.535(2) |
CT-guided biopsies (37/65) | 1/4 (25.0%) | 36/61 (59.0%) | 0.307(2) |
Source of infection (129/187, 69.0%) | |||
Hematogenous spread | < 0.001(1) | ||
Gastrointestinal tract infection | 3/18 (16.7%) | 6/111 (5.4%) | |
Respiratory tract infection (pneumonia) | 0/18 (0.0%) | 16/111 (14.4%) | |
Urinary tract infection (urosepsis) | 9/18 (50.0%) | 4/111 (3.6%) | |
Skin infection | 3/18 (16.7%) | 34/111 (30.6%) | |
Foreign body-associated infection (joint replacements, venous access port, prosthetic heart valve, and screws elsewhere in spine) | 2/18 (11.1%) | 21/111 (18.9%) | |
Odontogenic infection | 0/18 (0.0%) | 5/111 (4.5%) | |
Retropharyngeal & prevertebral infection | 1/18 (5.6%) | 5/111 (4.5%) | |
Post-interventional | |||
Epidural administration such as spinal infiltration (facet joint, epidural, periradicular) or epidural catheter analgesia | 0/18 (0.0%) | 20/111 (18.0%) | |
Coagulase-negative Staphylococci (CoNS)
Sepsis (CoNS: 4, 20.0% vs. OB: 90, 53.9%, p = 0.004), and length of ICU stay (CoNS: 2 [1‐18] d vs. OB: 6 [1–53] d, p = 0.037) were less frequent in CoNS than in OB. However, no differences were found in septic embolism (CoNS: 3, 20.0% vs. OB: 47, 34.8%, p = 0.387), endocarditis (CoNS: 2, 12.5% vs. OB: 21, 14.5%, p = 1.0), relapse rate (CoNS: 3, 18.8% vs. OB: 25, 23.4%, p = 1.0), disease-related mortality (CoNS: 0, 0.0% vs. OB: 10, 6.0%, p = 0.604), and length of hospital stay (CoNS: 34 [17–135] d vs. OB: 32 [9–165] d, p = 0.381).
The diagnostic sensitivity for detecting CoNS was in intraoperative specimens higher compared to OB (CoNS: 20, 100.0% vs. OB: 137, 82.0%, p = 0.048). However, no differences were observed in blood cultures (CoNS: 9, 45.0% vs. OB: 109, 65.3%, p = 0.089), and CT-guided biopsies (CoNS: 2/3, 66.7% vs. OB: 35/62, 56.5%, p = 1.0).
The sources of infection in CoNS differed in distribution from OB (p = 0.005), particularly in relation to skin infections (CoNS: 1, 7.7% vs. OB: 36, 31.0%) and foreign body-associated infections (CoNS: 8, 61.5% vs. OB: 15, 12.9%) (Table 6).
Table 6
Clinical characteristics of Coagulase-negative Staphylococci
Total n = 187 | Coagulase-neg. Staphylococci (20, 10.7%) | Other bacteria (167, 89.3%) | p-value |
|---|---|---|---|
Sex | M:14 (70.0%) F: 6 (30.0%) | M: 106 (63.5%) F: 61 (36.5%) | 0.630(2) |
Age | 67 [47–82] y | 69 [23–90] y | 0.839(3) |
Spondylodiscitis | 15 (75.0%) | 110 (65.9%) | 0.464(2) |
Isolated spinal epidural empyema | 5 (25.0%) | 57 (34.1%) | |
Sepsis | 4/20 (20.0%) | 90/167 (53.9%) | 0.004(2) |
Septic embolism | 3/15 (20.0%) | 47/135 (34.8%) | 0.387(2) |
Endocarditis | 2/16 (12.5%) | 21/145 (14.5%) | 1.0(2) |
Relapse rate | 3/16 (18.8%) | 25/107 (23.4%) | 1.0(2) |
Disease-related mortality | 0/20 (0.0%) | 10/167 (6.0%) | 0.604(2) |
Length of hospital stay | 34 [17–135] d | 32 [9-165] d | 0.381(3) |
Length of intensive care unit stay | 6 [1–53] d | 0.037(3) | |
Spinal localization | |||
Cervical spine | 3 (15.0%) | 56 (33.5%) | 0.126(2) |
Thoracic spine | 7 (35.0%) | 68 (40.7%) | 0.810(2) |
Lumbar spine | 15 (75.0%) | 108 (64.7%) | 0.458(2) |
Bacterial detection via | |||
Blood cultures | 9 (45.0%) | 109 (65.3%) | 0.089(2) |
Intraoperative specimens | 20 (100.0%) | 137 (82.0%) | 0.048(2) |
CT-guided biopsies (37/65) | 2/3 (66.7%) | 35/62 (56.5%) | 1.0(2) |
Source of infection (129/187, 69.0%) | |||
Hematogenous spread | 0.005(1) | ||
Gastrointestinal tract infection | 0/13 (0.0%) | 9/116 (7.8%) | |
Respiratory tract infection (pneumonia) | 1/13 (7.7%) | 15/116 (12.9%) | |
Urinary tract infection (urosepsis) | 1/13 (7.7%) | 12/116 (10.3%) | |
Skin infection | 1/13 (7.7%) | 36/116 (31.0%) | |
Foreign body-associated infection (joint replacements, venous access port, prosthetic heart valve, and screws elsewhere in spine) | 8/13 (61.5%) | 15/116 (12.9%) | |
Odontogenic infection | 0/13 (0.0%) | 5/116 (4.3%) | |
Retropharyngeal & prevertebral infection | 0/13 (0.0%) | 6/116 (5.2%) | |
Post-interventional | |||
Epidural administration such as spinal infiltration (facet joint, epidural, periradicular) or epidural catheter analgesia | 2/13 (15.4%) | 18/116 (15.5%) | |
Anaerobic bacteria
Anaerobic bacteria were equally detected in SD and ISEE patients (SD: 3, ISEE: 3). Women were more frequently affected than men (women: 5, men: 1) and the median age was 80 [78–82] years. Two patients had septic embolism, and sepsis, but none had endocarditis or died, whereas one patient suffered a relapse. Patients spent 24.5 [13.5–34] days in the hospital and 1.5 [1–7.5] days on the ICU. All bacteria were identified only by intraoperative specimens. Three bacteria were found in the CS, one in the TS, and 2 in the LS. Retropharyngeal, and odontogenic infections were the primary of infections.
MRSA
The “MRSA subgroup” of 2 male and 3 female patients aged 81 [80–83] years was observed in 4 SD patients and one patient with ISEE. Sepsis was observed in 3 patients and endocarditis in 2 patients, but septic emboli did not occur. We found two relapses, but no in this subgroup. Prolonged hospital stay of 56 [24–58] days and ICU stay of 16 [1–44] days were recorded. In blood cultures and intraoperative specimens, four bacteria were detected, while two were detected in CT-guided biopsies. MRSA was diagnosed twice in the CS, once in the TS, and two times in the LS. Respiratory, gastrointestinal, and skin infections were the primary sources.
Pseudomonas aeruginosa
In three men and one woman aged 72 [71–75] years, P. aeruginosa caused three SD and one ISEE. Two patients had sepsis and one endocarditis, while no patient had a relapse or died. Patients spent 20 [18‐29] days in the hospital and no day in the ICU 0 [0–5]. All bacteria were identified in intraoperative specimens and 2 of them in blood culture. Two patients underwent CT-guided biopsy of the psoas muscles, which was successful in one of them. Three bacteria were found in the TS and one in the CS, whereas LS was not affected. Respiratory and retropharyngeal infections were the source of the infections.
Polymicrobial Infections
In our cohort polymicrobial infections caused only spondylodiscitis and were documented in 8 patients. Candida albicans accounted for half of the polymicrobial infections and it was always associated with S. aureus (2 MSSA, 2 MRSA). B. fragilis was founded in infections with P. aeruginosa. C. acnes was present as a co-infection in MSSA infection. S. epidermidis was detected in a S. anginosus infection.
Therapy was adjusted according to the antibiogram. One patient died during treatment, and relapse was observed in 3 patients. The source of infection was pneumonia in two patients, gastrointestinal infection in 3 cases, per continuitatem spread of infection in two cases, and infection due to foreign body in one patient.
Discussion
Our study provides insights into the bacterial spectrum and related clinical courses in SD and ISEE and identifies several bacterial group-related profiles. GPB were more frequently detected than GNB and exclusively caused infective endocarditis in our study. Previous studies showed that GPB was more common than GNB in ISEE and SD [8].
MSSA was the most common bacterium in SD and ISEE in our cohort, representing more than half of cases, which is consistent with the literature [12, 17‐22]. In our study, MSSA occurred more frequently in ISEE than in SD, which was also observed by Stangenberg et al. [12]. MSSA occurred more frequently in CS than OB in our cohort, which previous studies have confirmed [12, 23‐25]. Skin infections and epidural administrations such as infiltration therapies were the most source of infection in the “MSSA subgroup”. This is in line with studies showing that MSSA was common source of skin infections with spinal involvement [26‐28].
The “SE subgroup” were the second most frequent bacterial subgroup in our study, causing 16.6% of infections, as reported in most studies [11, 29‐31]. Nonetheless, some authors observed S. epidermidis being the second common causative bacteria [12, 22]. Endocarditis was more frequently found in the “SE subgroup”, in accordance with previous studies [11, 29]. Streptococcus spp. and Enterococcus spp. were detected more frequently in SD and less in ISEE, which has not been reported in literature yet. In accordance with the European diagnostic guidelines, we recommend first collecting blood cultures and then image-guided biopsy or open surgery, whereby the diagnostic sensitivity of intraoperative specimens in our study was lower in the “SE subgroup” (61.3%) and higher in the “CoNS subgroup” (100.0%) [Lazzeri, 2019 #48]. Other methods such as blood culture and CT-guided biopsy of psoas abscess showed no difference between the pathogen groups.
Anzeige
Infections with CoNS have increased recently due to the potential ability to biofilm formation and colonization in various surfaces, as well as the increasing use of medical implants [32]. One possible other cause would be the increasing sonication examination of foreign bodies. CoNS was associated with a shorter ICU stay and less sepsis and could always be isolated by intraoperative specimens, which was due to the detection of infected foreign bodies. In line with other studies, the source of infection in CoNS in our collective was frequently a foreign body-associated infection such as port infection [11, 33‐35]. S. epidermidis is the second most common single bacteria after MSSA in our cohort (n = 18, 9.6%) and forms the fourth largest subgroup of SD and ISEE. Th previous studies reported similar results with a few exceptions [12, 22, 35, 36].
Enterobacterales were the main representatives of GNB and caused 10.7% of SD and ISEE in our collective. The literature data on the frequency of this subgroup in SD and ISEE varies widely [12, 22, 35]. Endocarditis was associated less frequently with Enterobacterales, in accordance with the literature data showing that endocarditis occurs in more than 80% of patients with GPB [11, 23]. Consistent with reported literature, the main source of infection in this subgroup was urinary tract infections [11, 35].
The “Anaerobic subgroup” could only be detected in intraoperative specimens, which showed the importance of this procedure. MRSA increased hospital length of stay to 56 days and ICU length of stay to 16 days, demonstrating the complexity of managing this infection, whereas patients with P. aeruginosa spent only 20 days in the hospital and no day in the ICU. Polymicrobial infections showed a complicated course and were half associated with C. albicans, which has not been previously investigated.
Limitation and strengths of this study
Our study is limited by its retrospective design and a possible selection bias toward the more severe cases due to the high degree of specialization at our university center. Nevertheless, our data derived from detailed clinical, imaging, and microbiological state-of-the-art diagnostic assessment with high internal validity and a meaningful sample size Lastly, the generalizability of our observations is limited by the monocentric design of our study. The study spanned 20 years, and the number of patients per year is not large enough to make a conclusion about the distribution and transformation of the pathogens over a period of time.
Conclusions
Our study shows that the bacterial groups in SD and ISEE have distinct bacterial-related patterns, which may help modify guidelines towards more tailored management.
GPB dominated the bacterial spectrum of SD and ISEE and were solely responsible for endocarditis. The most frequently isolated strain was MSSA, which was found more often in patients with skin infections and in the CS compared to other bacteria. Streptococci and enterococci were more frequently isolated in intraoperative specimens, were more frequently considered the cause of endocarditis, and were more often found in SD than in ISEE. CoNS resulted in less sepsis, shorter ICU stay, and was frequently associated with foreign body infection. Enterobacterales were the main representatives of GNB that did not cause endocarditis and were associated with urinary tract infections. Anaerobic bacteria could only be detected in intraoperative specimens in our study. In addition, MRSA increased hospital and ICU length of stay.
Acknowledgements
Not applicable.
Declarations
Ethics approval and consent to participate
The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the local ethics committee at the University Hospital Dresden (protocol code: BO-EK-17012022, January 2022). Patient informed consent was waived by the local ethics committee at the University Hospital Dresden due to the retrospective, anonymous character of this study.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.